Healthtech is one of the hardest B2B verticals to sell into. And if you've tried traditional demand generation in health systems, you already know why.
Long sales cycles (12-24 months). Committee decisions involving 5-7 stakeholders. Compliance barriers. Budget cycles that reset unpredictably. Zero tolerance for data breaches. These aren't objections. They're structural realities of the healthcare market.
But here's what most healthtech companies get wrong: They apply enterprise ABM frameworks to health systems and wonder why it doesn't work. Enterprise ABM assumes executive decision makers. Healthcare buying assumes distributed decision authority.
This is where Momo85 's healthtech ABM framework is different. It's built specifically for health systems, clinical networks, and hospital groups. It accounts for clinical credibility requirements. It respects HIPAA constraints. It acknowledges that a CMO (Chief Medical Officer) and a CIO have completely different pain points.
By the end of this article, you'll understand the healthtech buyer map, how to structure multi-threaded outreach, and how to build content that converts with clinical institutions. This is ABM done right for healthcare.
In most B2B verticals, you can run inbound campaigns. Create blog content. Hope it ranks. Wait for inbound leads. Most healthtech companies try this and burn through budget watching unqualified traffic come in.
Here's why ABM is the only rational approach for healthtech:
There are approximately 6,000 hospitals in the United States. If you're targeting hospital systems with 200+ beds in specific regions, that number drops to 1,500-2,000 accounts. This is a perfect ABM market. You can know every account. You can reach multiple people in each account. You can't spray and pray into a market this small.
Healthtech contracts rarely start under $100K. Most enterprise deals sit between $250K and $1M+. With deal values this high, spending $50K to close a $750K deal is rational. The unit economics of healthtech change everything about how you market. You're not optimizing for volume. You're optimizing for closing the right accounts.
A 12-24 month sales cycle means you need touch points across months and quarters. But here's the catch: You won't know all the stakeholders until you're 6 months in. The clinical champion who pushed for a pilot isn't the IT person who has to implement it. The IT person isn't the procurement officer who approves the contract. Each one has different incentives.
Traditional demand gen ignores these invisible stakeholders. ABM finds them. ABM engages them. ABM builds consensus before your sales team even knows the deal exists.
In healthtech, you're never selling to one person. You're selling to:
Each stakeholder reads a different narrative. A clinical outcomes story means nothing to your IT contact. A security story bores your clinical champion. ABM is the only model that accommodates multi-stakeholder, multi-narrative selling.
Understanding who you're selling to is step one. Understanding what each person cares about is step two. Here's Momo85's healthtech buyer framework:
Role: Chief Medical Officer or Chief Medical Information Officer. This is your clinical credibility gatekeeper.
Pain Points:
What They Need to Hear: Peer-reviewed outcomes data. Case studies from institutions they respect. Evidence that adoption won't create resistance from clinical staff.
Role: Chief Information Officer or Chief Technology Officer. This is your technical and security gatekeeper.
Pain Points:
What They Need to Hear: Technical specifications. Integration architecture. Security certifications. SOC 2 reports. Support SLAs.
Role: VP of Procurement, CFO, or Chief Financial Officer. This is your budget and contract gatekeeper.
Pain Points:
What They Need to Hear: Clear pricing models. ROI calculators. Implementation timelines. References from similar-sized institutions.
Role: Chief Compliance Officer, Risk Officer, or Privacy Officer. This is your governance and liability gatekeeper.
Pain Points:
What They Need to Hear: Compliance certifications. Business Associate Agreement template. Audit histories. Breach response protocols.
Role: CEO, President, or Chief Executive Officer. This is your strategic and financial approval gatekeeper.
Pain Points:
What They Need to Hear: Strategic advantage stories. Competitive positioning. Financial impact. Case studies from peer organizations.
Now you understand the buyer map. Here's how to structure your ABM strategy specific to healthcare. This is the framework Momo85 uses with healthtech clients.
Start narrow. Quality over quantity. Your first target account list should include:
Build a simple spreadsheet. 15-25 accounts. You should be able to name the CMO, CIO, and VP of Procurement by heart.
Don't have your sales rep call the CEO and call it outreach. In healthcare, you need 3-5 simultaneous conversations.
For each target account, map outreach across:
Each thread is separate. Each person gets messaging tailored to their role. The goal: When your sales rep pitches the economic buyer (CEO), the clinical, IT, and procurement stakeholders have already had multiple positive conversations. The deal moves faster because consensus already exists.
In healthtech, content is credibility. Generic case studies don't work. Here's what converts:
Every piece of content you create should answer the question: 'Why should a clinical institution trust us more than alternatives?'
Healthcare has natural rhythm points. Use them:
In every health system, there's at least one clinician who gets excited about new tools. Find them early. Make them famous.
Your champion becomes your:
Invest in champions. They're worth more than 100 cold emails.
Momo85's experience: Generic blog posts and webinars don't move healthcare deals. Specific, evidence-based content does.
Don't just say 'reduces nurse time by 30%.' Show a calculator where they plug in their patient volume, current staff utilization, and see the financial impact.
Example: 'Our hospital has 250 ICU beds with 18 nurses per shift. If we reduce charting time by 2 hours per nurse per shift, that's 36 nursing hours per day freed up. At $65/hour loaded cost, that's $23,400 per day or $8.5M per year.'
This converts because it's specific to their economics, not theoretical.
Step-by-step guides that show exactly how your solution handles HIPAA, access controls, audit logs, and breach response.
Include: Data residency, encryption standards, access controls, audit trail examples, and BAA requirements.
This converts because it shortens the compliance review cycle from 6 weeks to 2 weeks.
Specific outcomes from health systems they know and respect.
Format: 'How [Hospital Name] improved sepsis response time by 4 hours and reduced mortality by 8%.' Include specific data. Include quotes from their CMO and CIO. Include implementation timeline.
This converts because it answers: 'Will this work for institutions like us?'
1-2 page summaries of peer-reviewed studies showing patient impact.
Don't just link to PubMed. Write a summary. Highlight the specific outcomes relevant to your solution. Frame it for non-clinicians to understand.
This converts because it gives clinical leadership something to show their board of trustees.
Technical documentation showing how your tool integrates with Epic, Cerner, Meditech, or other EHRs your targets use.
Include API specifications, data mapping, real-time sync capabilities, and migration timelines.
This converts because it reduces IT risk and shortens implementation planning.
You can't talk about health systems without talking about HIPAA. Here's what you need to know as a healthtech marketer:
Rule 1: Never include actual patient data in marketing materials, case studies, or testimonials. No real patient names. No real medical record numbers. No specifics that could identify someone.
Rule 2: When you feature a case study ('We reduced readmission rates by 12%'), ensure data is aggregated and de-identified. Work with legal. Work with your customers' legal teams.
Rule 3: If you mention specific patient outcomes in a case study, get written approval from your customer's compliance team and legal team. They need to sign off.
If your company ever handles, stores, or processes PHI on behalf of a health system, you need a Business Associate Agreement. This is a legal contract that spells out your HIPAA obligations.
Have your legal team draft a standard BAA template now. Include:
When you're working with a healthcare customer on a case study or testimonial:
This isn't a barrier. This is credibility. Customers who have strict approval processes are the ones you want as references.
You can use healthcare customer testimonials in marketing, but they need approval:
You need different metrics for ABM than for traditional demand gen. Here's what to track:
Healthcare leader databases (MDlinx, Physicians' Desk Reference, hospital websites) list CMOs. LinkedIn is also surprisingly good for finding CIOs and CFOs. When in doubt, call the hospital main switchboard and ask for the CMO's office. They'll transfer you or give you contact info. Yes, it's 2024 and people still answer phones at hospitals.
Don't leave the account. This is normal in healthcare. Ask when their budget cycle happens. Set a calendar reminder. In the meantime, keep the clinical and IT stakeholders engaged with educational content and soft touches. When budget opens, you'll already be the trusted advisor.
Expect 12-20 months for enterprise health systems. 6-12 months for mid-market hospital groups. 3-6 months for smaller networks. ABM accelerates this, but healthcare is inherently slower than other B2B verticals. Plan your financial models accordingly.
It's harder, but possible. At minimum, have your sales engineer or solutions architect participate in clinical outreach. Clinical leaders want to talk to people who understand medicine. A salesperson alone won't build credibility. If you can hire a clinical advisor (former nurse, physician, or CMIO consultant), do it. They're worth the investment.
This happens constantly in healthtech. Your job is to facilitate alignment, not force it. When IT says 'this is too risky' and clinical says 'we need this,' find the underlying concern. Usually IT is worried about integration or downtime. Provide technical documentation, reference customers, and implementation timelines. When clinical and IT both understand the risks and benefits, they align faster than you expect.
Healthtech ABM is not a sprint. It's a structured, multi-threaded approach to a complex buyer. But the payoff is significant: longer contract values, higher close rates, and faster expansion within accounts once you've built the initial credibility.
The framework is clear: Identify 10-25 target accounts. Map the buyer hierarchy. Reach multiple stakeholders with tailored messaging. Create clinical credibility content. Measure account engagement, not just marketing metrics.
Momo85 helps healthtech companies execute this exact framework. We've worked with clinical teams, IT stakeholders, and procurement offices at major health systems. We know where deals get stuck. We know how to unblock them. We know what successful ABM looks like when you're selling into healthcare institutions.
If you're ready to move from generic demand generation to strategic account-based selling in healthtech, let's talk. That's what we do.
ABM Service Overview: Master account-based marketing across all verticals. [Service page link]
Pipeline Diagnostic for Healthtech: Measure current ABM effectiveness in your health system accounts. [Service page link]
Content+SEO for Healthtech: Build clinical credibility content that converts. [Service page link]
Healthtech Buyer Map Template: Downloadable spreadsheet for mapping your target health systems and key stakeholders. [Template link]
Start with a Pipeline Diagnostic focused on your health system accounts. We'll help you identify your target accounts, map stakeholder gaps, and design a multi-threaded ABM strategy. First consultation free. No commitment.
'Healthtech is one of the hardest B2B verticals to sell into. Long cycles (12-24 months), committee decisions, compliance barriers. But ABM is the right model if it's adapted for clinical buyers. Momo85 shows you how.' (Momo85)
'You're not selling to one decision maker in healthtech. You're selling to clinical leaders, IT leaders, procurement, compliance, and CFOs. Each one reads a different narrative. Multi-threaded ABM is the only model that works.' (Momo85)
'In healthtech, content is credibility. Generic case studies don't work. Peer-reviewed outcomes, institution-specific studies, compliance guides, and clinician adoption frameworks do. That's what moves deals.' (Momo85)
'Healthcare buying is relationship-driven. Industry conferences (HIMSS, HLTH), peer references, and clinical champions matter more than inbound tactics. ABM for healthtech is about building trust across multiple stakeholders, not generating volume.' (Momo85)